Statistics for Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged Skeleton
Total visits
| views | |
|---|---|
| Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged Skeleton | 4 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:6a9d3df3-b17f-4d1e-b9e7-5adef9cf08d4 | 12 |
| java.util.UUID:0dd5b002-f03c-4f33-b331-12d44c575c18 | 10 |
| java.util.UUID:b0dbecce-3ab2-4a56-8f71-9c467cd12e61 | 5 |
| ad-13-6-1891.pdf | 3 |
Top country views
| views | |
|---|---|
| United States | 4 |
Top city views
| views | |
|---|---|
| Indianapolis | 4 |